Stanford and Intonation partner to develop new treatments fo

Stanford University's Innovative Medicines Accelerator (IMA) and Intonation Research Laboratories (Intonation) have formed a collaboration to develop treatments that target cancerous neuroendocrine tumors, or tumors that form from hormone-releasing cells.

Related Keywords

India , Mark Smith , Marc Tessier Lavigne , Sureshk Jain , Chaitan Khosla , Justin Annes , Jennifer Lipschultz , Megan Craig , Intonation Research Laboratories , Stanford University Innovative Medicines Accelerator , Stanford University , Invus Group , Stanford School Of Medicine , Innovative Medicines Accelerator , Stanford School , Jennifer Lipschultz Director , Stanford Innovative Medicines , Research , Ormone , Laboratory , Medicine , Translation ,